Weekly Movers

LCI Receives FDA Approval for New Drug

September 28th, 2017

Lannett Company (LCI) announced on September 27 that is had received FDA approval for a new drug. The Oxycodone and Acetaminophin tablets USP, 5 mg/325 mg and 10 mg/325 mg are the therapeutic equivalent to the drug Percocet. U.S. sales of Oxycodone...

Read More

ALJ Regional Holdings Purchases New Printing Facilities

September 28th, 2017

On September 20, Phoenix Color Corp, a wholly owned subsidiary of ALJ Regional Holdings, entered into an asset purchase agreement with LSC Communications and Moore-Langen Printing. In the agreement, ALJ will obtain printing and manufacturing...

Read More

SAGE Clinical Trial Fails

September 28th, 2017

Sage Therapeutics announced disappointing results on its late-stage clinical trial of a brexanolone treament for a seizure disorder called super-refractory status epilepticus (SRSE). Right now there is no U.S. drug approved for the condition. Sonal...

Read More

Five-Day Trend Shows Markets Like HK Divestiture Plans

September 27th, 2017

On September 20, Halcon Resources (HK) announced plans to divest its remaining non-operated oil assets in the Williston Basin to an undisclosed company for $104 million. Halcon started selling assets in the Williston Basin earlier this year in order...

Read More

Interested in events that actually move the market?Awesome!

Let us send you a recap of every weeks market movers!

Better yet…Receive ALERTS
of Market Moving Events…
seconds after they surface!

  • Mergers & Acquisitions
  • Clinical Trials
  • Contract Awards
  • Stock Repurchase Programs
  • Earnings Announcement

Get Started